9th Annual Biomarkers Congress
Cardiovascular Research Technologies (CRT) 2013 Atherosclerosis, Plaque Imaging and Lipid Therapy


Washington, District of Columbia
http://www.crtmeeting.org/default.aspx
Cardiovascular Research Technologies (CRT) 2013 will take place 
from February 23 - 26, 2013 in Washington DC. This year’s conference 
will be the most comprehensive to date. CRT 2013 has many 
new and exciting features, including a new, cutting-edge Valve & Structural 
Heart track, in addition to its standard five subject areas -- Coronary, Endovascular, Science, Technology and Nurse & Tech. 
Also new this year will be the Essentials of Clinical Research course as well as more exciting hands-on workshops and simulations.

Schedule of Presentations:

Monday, February 25, 2013
08:00:00 Atherosclerosis, Plaque Imaging and Lipid Therapy | Abstract Café
09:00:00 Atherosclerosis, Plaque Imaging and Lipid Therapy | The OCT/FFR/IVUS: Workshop from Mixed Case Studies William Fearon, Giulio Guagliumi, Marco A. Costa, Gary S. Mintz
09:35:00 Atherosclerosis, Plaque Imaging and Lipid Therapy | NEW INSIGHTS INTO THE PATHOPHYSIOLOGY OF THE ATHEROSCLEROTIC PLAQUE Robert Wilensky, Pedro R. Moreno
09:40:00 Atherosclerosis, Plaque Imaging and Lipid Therapy | New Pathologic Insights into Atherosclerosis Progression and Thrombosis Renu Virmani
09:50:00 Atherosclerosis, Plaque Imaging and Lipid Therapy | The Role of Inflammation and Immune Responses Robert Wilensky
10:00:00 Atherosclerosis, Plaque Imaging and Lipid Therapy | Can Imaging Modalities Detect Vulnerable Plaque? Gregg W. Stone
10:10:00 Atherosclerosis, Plaque Imaging and Lipid Therapy | Near Infrared as a Monitor for Medical Therapy Pedro R. Moreno
10:20:00 Atherosclerosis, Plaque Imaging and Lipid Therapy | Will HeartFlow's FFRct Change the Paradigm for Managing Coronary Disease?
10:30:00 Atherosclerosis, Plaque Imaging and Lipid Therapy | Should We Use OCT in STEMI Patients? Marco A. Costa
10:40:00 Atherosclerosis, Plaque Imaging and Lipid Therapy | OCT Use in Stent Thrombosis and Neoatherosclerosis Gary S. Mintz
10:50:00 Atherosclerosis, Plaque Imaging and Lipid Therapy | OCT and Vulnerable Plaque: Natural History Studies Sergio Waxman
11:00:00 Atherosclerosis, Plaque Imaging and Lipid Therapy | Near Infrared Spectroscopy (NIRS): Technology Update James E. Muller
11:05:00 Atherosclerosis, Plaque Imaging and Lipid Therapy | Near Spectroscopy: Lessons Learned from COLOR Giora Weisz
11:15:00 Atherosclerosis, Plaque Imaging and Lipid Therapy | Can IVUS be Used to Assess Intermediate Lesions Ron Waksman
11:25:00 Atherosclerosis, Plaque Imaging and Lipid Therapy | IFFR Versus FFR: What are the Differences?” Habib Samady
11:35:00 Atherosclerosis, Plaque Imaging and Lipid Therapy | Panel Discussion: Will OCT Become a Clinical Tool or Will It Remain a Research Tool? Habib Samady, Marco A. Costa, Robert Wilensky, Giora Weisz, Neil J. Weissman, Gregg W. Stone, James E. Muller, Pedro R. Moreno, Gary S. Mintz
12:00:00 Atherosclerosis, Plaque Imaging and Lipid Therapy | Lunch and Visit the Exhibits and Simulators
13:55:00 Atherosclerosis, Plaque Imaging and Lipid Therapy | IMAGING OF THE VULNERABLE PLAQUE Neil J. Weissman
14:00:00 Atherosclerosis, Plaque Imaging and Lipid Therapy | Angioscopic and Virtual Histology Intravascular Ultrasound: Characteristics of Culprit Lesion Morphology Underlying Coronary Artery Thrombosis Akiko Maehara
14:10:00 Atherosclerosis, Plaque Imaging and Lipid Therapy | An Aggregate of Three Biomarkers Predict Very High Risk of AMI and Death Stephen E. Epstein
14:20:00 Atherosclerosis, Plaque Imaging and Lipid Therapy | Lessons from the OCTAVIA Trial Giulio Guagliumi
14:30:00 Atherosclerosis, Plaque Imaging and Lipid Therapy | Shear Stress and Prediction of Vulnerable Plaque Peter H. Stone
14:30:00 Atherosclerosis, Plaque Imaging and Lipid Therapy | Shear Stress and Prediction of Vulnerable Plaque Giulio Guagliumi
14:40:00 Atherosclerosis, Plaque Imaging and Lipid Therapy | Break
14:50:00 Atherosclerosis, Plaque Imaging and Lipid Therapy | ATHEROSCLEROSIS & LIPID MANAGEMENT Bryan Brewer
14:55:00 Atherosclerosis, Plaque Imaging and Lipid Therapy | LDL-C vs. Non-HDL as a Target to Reduce Cardiovascular Disease in the Diabetic Patient W. Virgil Brown
15:10:00 Atherosclerosis, Plaque Imaging and Lipid Therapy | HDL as a Target to Reduce Residual Cardiovascular Risk in Statin Treated Patients Steven E Nissen
15:25:00 Atherosclerosis, Plaque Imaging and Lipid Therapy | Are Triglycerides a Risk Factor For Cardiovascular Disease? Michelle Miller
15:40:00 Atherosclerosis, Plaque Imaging and Lipid Therapy | Update on the Role of Niacin in the Treatment of the High Risk Cardiovascular Patient
15:55:00 Atherosclerosis, Plaque Imaging and Lipid Therapy | Role of Dysfunctional HDL in Cardiovascular Disease Benjamin J. Ansell
16:10:00 Atherosclerosis, Plaque Imaging and Lipid Therapy | Panel Discussion: TBA Benjamin J. Ansell, Michelle Miller, Steven E Nissen, Bryan Brewer
16:20:00 Atherosclerosis, Plaque Imaging and Lipid Therapy | Status Report on Clinical Trials with RVX 208, A Novel Mechanism to Increase HDL by Selectively Increasing ApoA-I Synthesis Norman C. W. Wong
16:35:00 Atherosclerosis, Plaque Imaging and Lipid Therapy | Update on Clinical Trials with Dalcetrapib, a Novel CETP Modulator to Raise HDL David G. Kallend
16:50:00 Atherosclerosis, Plaque Imaging and Lipid Therapy | Update on the Function of HDL in Anacetrapib Treated Patients Douglas S. Johnson
17:05:00 Atherosclerosis, Plaque Imaging and Lipid Therapy | Evacetrapib: Lipoprotein Profile and Clinical Trial of a Novel CETP Inhibitor Jeffrey S Riesmeyer
17:20:00 Atherosclerosis, Plaque Imaging and Lipid Therapy | Update on HDL Infusions and Atherosclerosis Regression in the ACS Patient Bryan Brewer
17:35:00 Atherosclerosis, Plaque Imaging and Lipid Therapy | Panel Discussion: TBA
17:45:00 Atherosclerosis, Plaque Imaging and Lipid Therapy | Adjourn
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.